Friday, December 3, 2021
ADVT 
Health

News of potential COVID vaccine 'encouraging': PM

Darpan News Desk The Canadian Press, 09 Nov, 2020 06:07 PM
  • News of potential COVID vaccine 'encouraging': PM

Prime Minister Justin Trudeau says he hopes to see COVID-19 vaccines roll out in Canada early next year, but warns that won't bring an immediate resolution to the pandemic currently seeing a resurgence in several provinces.

The prime minister says news from Pfizer today that one of its vaccine candidates appears very effective in clinical trials is "very encouraging" but won't help anyone who catches the virus in the meantime.

Speaking in Ottawa, Trudeau said other vaccine candidates have also appeared to progress well.

His comments come after a weekend that saw the two provinces hardest hit by the pandemic report record-breaking daily case counts.

Quebec reported 1,397 new cases on Sunday and Ontario reported 1,328, nearly 200 more than the record it had set the previous day.

The number of new infections stayed above 1,000 in Ontario on Monday, with 1,242 reported.

Canada has bought the rights to 20 million doses of Pfizer's vaccine, if it proves effective and Health Canada approves it for use here, and Trudeau said the government would purchase more if the initial round goes well.

The company said in a news release that early results from a large-scale trial show its vaccine is 90 per cent effective at combating the virus.

Tedros Adhanom Ghebreyesus with the World Health Organization also reacted to the good news via Twitter.

"We hope to see vaccines landing in the early next year but between now and then it's really really important that we double down on our efforts," Trudeau said.

"We need to make sure we are controlling the spread of COVID-19 in the coming months so that when vaccines get here we will be able to act quickly to protect all Canadians."

MORE Health ARTICLES

Scientists get closer to blood test for Alzheimer's disease

Scientists get closer to blood test for Alzheimer's disease

An experimental blood test was highly accurate at distinguishing people with Alzheimer’s disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia.

Scientists get closer to blood test for Alzheimer's disease

COVID-19 recovery can take a few weeks even for young adults

COVID-19 recovery can take a few weeks even for young adults

Recovering from even mild coronavirus infections can take at least two to three weeks, according to U.S. research published Friday.

COVID-19 recovery can take a few weeks even for young adults

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support

DO WATCH & PLEASE SHARE AS MUCH AS POSSIBLE! Baby Aryan's parents urge the community to help as the baby was diagnosed with TYPE 1 SPINAL MUSCULAR ATROPHY (SMA). There is a treatment available called ZOLGENSMA which is the most expensive drug in the world at this time it costs 2.1 million dollars USD (2.8 Million CAD).

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support

FDA tells doctors to discuss overdose antidote with patients

FDA tells doctors to discuss overdose antidote with patients

Doctors who prescribe opioid painkillers should tell their patients about a potentially life-saving medication that can reverse drug overdoses, according to new federal guidelines issued Thursday.

FDA tells doctors to discuss overdose antidote with patients

Virus antibodies fade fast but not necessarily protection

Virus antibodies fade fast but not necessarily protection

New research suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness, but that doesn’t mean protection also is gone or that it won’t be possible to develop an effective vaccine.

Virus antibodies fade fast but not necessarily protection

FDA calls for removal of fruity, disposable Puff Bar vapes

FDA calls for removal of fruity, disposable Puff Bar vapes

U.S. health officials are cracking down on a brand of fruity disposable e-cigarettes that is popular with teenagers, saying the company never received permission to sell them in the U.S.

FDA calls for removal of fruity, disposable Puff Bar vapes